Cerca per...
-
22AprCOVID-19: The prompt reaction of the arbitration worldAmong the many questions the current times have raised is the compelling question of how litigation will be managed. The reaction of the arbitration world to this unprecedented emergency is rather encouraging.
-
22AprPrice gouging in Italy: is the Italian Competition Authority overstretching its consumer powers to exercise control over price increases related to the COVID-19 emergency?Price gouging cannot constitute per se a breach of the Italian Consumer Code, but it may raise the standard of diligence to discharge firms’ information obligations and aggravate a separate misleading conduct
-
22AprThe Italian Communications Authority and the Panzironi saga: an unprecedented six-month suspension for two broadcasters that hosted Mr. Panzironi’s special on “what they haven’t told you about coronavirus”AGCOM issued an unprecedented six-month suspension for two television broadcasters for hosting Mr. Panzironi’s program which could induce consumers to underestimate the risks of COVID-19
-
16Apr
-
10AprDecreto Liquidità: le principali misure a favore delle imprese volte a garantire la continuità aziendaleIl Decreto Liquidità ha sospeso l'applicazione di alcune disposizioni della legge sull'insolvenza per impedire agli operatori economici di liquidare le loro attività o di incorrere in procedure concorsuali a causa di COVID-19.
-
9AprCOVID-19 emergency: increasingly dematerialized prescriptionsBreaking news about e-prescriptions: Ordinance 651/2020 and Ministerial Decree of March 25, 2020 introduced alternative tools to paper memorandum of e-prescriptions.
-
9AprMedical Devices Regulation: EU Commission proposes a one year postponement of the application dateThe European Commission adopted a proposal to postpone the date of application of Medical Device Regulation by one year and deviate from the conformity assessment procedures in cases of emergency.Articolo inserito in: Life Sciences
-
9AprAIFA: latest indications for "remote" clinical trials during the COVID-19 health emergencyOn April 7, 2020, the Italian Medicines Agency (“AIFA”) provided guidance on the management of clinical trials in light of the restrictive measures adopted by the Government against the COVID-19 pandemic.
-
8AprCOVID-19 emergency: clinical trials and early access to drugsTo address the current emergency caused by COVID-19, several initiatives have been undertaken at the regulatory level to promote and facilitate clinical trials and early access to drugs.
-
8AprEmergenza Covid-19, ricette mediche sempre più dematerializzate: i prossimi stepL’Ordinanza del 19 marzo per limitare gli spostamenti delle persone, ha aumentato l’uso della ricetta elettronica, introducendo importanti novità nella comunicazione del promemoria. Facciamo il punto sul quadro normativo alla luce del DM del 25 marzo, che ha confermato alcune delle novità e ne ha introdotto altre